LANTHEUS HOLDINGS INC. - COMMON STOCK

Lantheus Reports Fourth Quarter and Full Year 2024 Financial Performance

26 Feb 2025 07:00:01 By Nasdaq GlobeNewswire

Lantheus to Present at Upcoming Investor Conferences

21 Feb 2025 08:30:00 By Nasdaq GlobeNewswire

Lantheus to Host Fourth Quarter and Full Year 2024 Earnings Conference Call and Webcast on February 26, 2025, at 8:00 a.m. Eastern Time

12 Feb 2025 08:00:00 By Nasdaq GlobeNewswire

Lantheus Announces Presentations Featuring PYLARIFY (Piflufolastat F 18) Data at the ASCO GU Meeting

05 Feb 2025 08:30:00 By Nasdaq GlobeNewswire

Lantheus Appoints Phuong Khanh (P.K.) Morrow, M.D., as New Board Member

30 Jan 2025 08:30:00 By Nasdaq GlobeNewswire

Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader

28 Jan 2025 06:00:00 By Nasdaq GlobeNewswire

Lantheus to Acquire Life Molecular Imaging for an Upfront Payment of $350 Million to Accelerate Innovation for Patients in the Growing Alzheimer’s Disease Radiodiagnostic Market

13 Jan 2025 00:05:00 By Nasdaq GlobeNewswire

Lantheus to Present at the Jefferies London Healthcare Conference

13 Nov 2024 08:30:00 By Nasdaq GlobeNewswire

Lantheus Continues to Commend CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY’s Blockbuster Status for 2025

11 Nov 2024 07:39:54 By Nasdaq GlobeNewswire

Lantheus Reports Third Quarter 2024 Financial Results

06 Nov 2024 07:00:01 By Nasdaq GlobeNewswire

Lantheus Applauds CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals, Advancing Patient Access and Care

04 Nov 2024 07:30:00 By Nasdaq GlobeNewswire

Lantheus to Host Third Quarter 2024 Earnings Conference Call and Webcast on November 6, 2024, at 8:00 a.m. Eastern Time

23 Oct 2024 08:30:00 By Nasdaq GlobeNewswire

Lantheus Presents Results from the Primary Analysis of Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024

15 Sep 2024 08:45:00 By Nasdaq GlobeNewswire

Lantheus Appoints Julie Eastland as New Board Member

05 Sep 2024 08:30:00 By Nasdaq GlobeNewswire

Lantheus to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

28 Aug 2024 08:30:00 By Nasdaq GlobeNewswire

Lantheus to Present Additional Clinical Data from Phase 3 Pivotal SPLASH Trial in PSMA-Positive Metastatic Castration-Resistant Prostate Cancer During ESMO Congress 2024

20 Aug 2024 08:30:00 By Nasdaq GlobeNewswire

Lantheus Reports Second Quarter 2024 Financial Results

31 Jul 2024 07:00:01 By Nasdaq GlobeNewswire

Lantheus to Host Second Quarter 2024 Earnings Conference Call and Webcast on July 31, 2024, at 8:00 a.m. Eastern Time

17 Jul 2024 08:30:00 By Nasdaq GlobeNewswire

NetDania - New 12 months High: LANTHEUS HOLDINGS INC. - COMMON STOCK

16 Jul 2024 09:45:06 By NetDania Notify

NetDania - New 12 months High: LANTHEUS HOLDINGS INC. - COMMON STOCK

15 Jul 2024 09:54:58 By NetDania Notify